Good Lifestyle

The ongoing discovery and rising variants of Covid-19s have been concerned with health officials that existing vaccine versions will not be effective against new strains. This is especially true ofVariant B.1.617.2, which has recently been discovered to be responsible for the devastating surge of India and half of all new global cases. But a new study determined how much the anti-Pfizer vaccine protects against the variant of India after administration of the two doses. Read it to see how effective the blows can be effective against the last strain.

RELATED:96% of people who get the vaccine against Pfizer have in common.

According to a recent study conducted between April 5 and May 16 by Public Health of England, the Pfizer-Biontech vaccine is88% effective Against symptomatic diseases of the variant Covidée B.1.617.2 two weeks after the second dose. The new research also showed that the vaccine was effective 93% two weeks after the second dose against the "British variant" B.1.1.7 which became the dominant voltage in the U.K. After being discovered in December.

"I am more and more confident that we are on the right track of the roadmap [for reopening] because these data show that the vaccine, after two doses, works as effectively [against the Indian variant]", secretary Indian health] ".Matt Hancock said in a press release.

RELATED:The Pfizer vaccine protects you at least this long study discovery.

The study also found that the shots also lowered the probability of serious results of the Variant of India, which spread tonearly 50 countries Including the United States and has been labeled a "variant concern" by the World Health Organization (WHO) at the beginning of May. "Effectiveness of the vaccine Against symptomatic diseases of variant B.1.617.2 is similar after 2 doses compared to the dominant B.1.1.1.7 (Kent) variant in the United Kingdom, and we anticipate even higher levels of efficiency against the Hospitalization and death, "the authors of the study wrote.

However, the results also found that the first dose of thePfizer vaccine with two shots Vitalize only 33% in force against B.1.617.2 after three weeks, compared to 50% in force against B.1.1.7. Hancock said that the most recent research "What is the importance of the second dose is to ensure the highest possible protection" against the propagation of CIVID-19 and its variants, adding that the reception of the two shots is "absolutely Vital ".

RELATED:These 2 vaccines are effective against the new variant of India, discovers a study.